Royal Bank of Canada’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63M | Buy |
|
|||||
|
2025
Q1 | $20K | Sell |
|
|||||
|
2024
Q4 | $51K | Sell |
|
|||||
|
2024
Q3 | $163K | Buy |
|
|||||
|
2024
Q2 | $117K | Buy |
|
|||||
|
2024
Q1 | $24K | Sell |
|
|||||
|
2023
Q4 | $107K | Sell |
|
|||||
|
2023
Q3 | $534K | Buy |
|
|||||
|
2023
Q2 | $852K | Sell |
|
|||||
|
2023
Q1 | $971K | Buy |
|
|||||
|
2022
Q4 | $26K | Buy |
|
|||||
|
2022
Q3 | $22K | Buy |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $339K | Sell |
|
|||||
|
2021
Q4 | $622K | Buy |
|
|||||
|
2021
Q3 | $812K | Buy |
|
|||||
|
2021
Q2 | $1.11M | Sell |
|
|||||
|
2021
Q1 | $1.31M | Sell |
|
|||||
|
2020
Q4 | $1.77M | Sell |
|
|||||
|
2020
Q3 | $706K | Sell |
|
|||||
|
2020
Q2 | $1.02M | Sell |
|
|||||
|
2020
Q1 | $646K | Sell |
|
|||||
|
2019
Q4 | $606K | Sell |
|
|||||
|
2019
Q3 | $472K | Buy |
|
|||||
|
2019
Q2 | $648K | Buy |
|
|||||
|
2019
Q1 | $430K | Sell |
|
|||||
|
2018
Q4 | $496K | Buy |
|
|||||
|
2018
Q3 | $700K | Buy |
|
|||||
|
2018
Q2 | $578K | Buy |
|
|||||
|
2018
Q1 | $533K | Sell |
|
|||||
|
2017
Q4 | $371K | Sell |
|
|||||
|
2017
Q3 | $1.01M | Sell |
|
|||||
|
2017
Q2 | $1.89M | Buy |
|
|||||
|
2017
Q1 | $1.83M | Buy |
|
|||||
|
2016
Q4 | $1.45M | Buy |
|
|||||
|
2016
Q3 | $655K | Buy |
|
|||||
|
2016
Q2 | $244K | Buy |
|
|||||
|
2016
Q1 | $29K | Buy |
|
|||||
|
2015
Q4 | $26K | Sell |
|
|||||
|
2015
Q3 | $48K | Buy |
|
|||||
|
2015
Q2 | $40K | Buy |
|
|||||
|
2015
Q1 | $18K | Sell |
|
|||||
|
2014
Q4 | $17K | Sell |
|
|||||
|
2014
Q3 | $55K | Buy |
|